Neuron Biolabs - Biosolutions for Application
Neuron Biolabs develops biosolutions for application in the pharmaceutical and agri-food industries through its specialised divisions. The Pharma division is dedicated fundamentally to the search for preventative drugs and treatments for neurodegenerative diseases, particularly Alzheimer’s disease. The Diagnostic division develops tools and biomarkers for the diagnosis of diseases of the Central Nervous System, as in the case of Alzheimer’s. The Services Division offers a wide range of R&D services in the fields of biomedicine, toxicology and agri-food. Neuron Bio offers preclinical R&D services for the biomedicine, toxicological and agro-food areas, developing tailor-made projects through the use of in vitro and in vivo models (efficacy and safety, behavior studies …) in multiple areas of study.
Scientific Milestones
- Pipeline consisting of 5 compounds for the central nervous system.
- 5 patent families.
- Discovery of 31 new molecules.
- Implementation of a drug discovery platform.
- Compound database consisting of 22,000 extracts.
- Development of a diagnostic tool for Alzheimer’s Disease (AlzTEST®).
Customer reviews
No reviews were found for Neuron Biolabs - Biosolutions for Application. Be the first to review!